Role of ST2 as a biomarker of respiratory dysfunction after interstitial pneumonia
Open Access
- 30 July 2021
- journal article
- Published by Peertechz Publications Private Limited in Open Journal of Asthma
- Vol. 5 (1), 007-008
- https://doi.org/10.17352/oja.000015
Abstract
Through stern social restraint measures, Italy has recently overcome the epidemic peak of COVID-19 (Coronavirus Disease-19) respiratory syndrome induced by SARS-CoV-2 and the attention is progressively moving toward its sequelae, especially on pulmonary fibrosis and the associated pulmonary functional decline [1-3].Keywords
This publication has 24 references indexed in Scilit:
- Plasma Concentrations of Soluble Suppression of Tumorigenicity-2 and Interleukin-6 Are Predictive of Successful Liberation From Mechanical Ventilation in Patients With the Acute Respiratory Distress Syndrome*Critical Care Medicine, 2016
- sST2 levels are associated with all‐cause mortality in anticoagulated patients with atrial fibrillationEuropean Journal of Clinical Investigation, 2015
- ST2 in Pulmonary DiseaseThe American Journal of Cardiology, 2015
- Soluble ST2 Testing: A Promising Biomarker in the Management of Heart FailureArquivos Brasileiros de Cardiologia, 2015
- ST2 in Emergency Department Patients With Noncardiac DyspneaAcademic Emergency Medicine, 2013
- The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitisClinical & Experimental Allergy, 2011
- Soluble ST2 Plasma Concentrations Predict 1-Year Mortality in Acutely Dyspneic Emergency Department Patients With Pulmonary DiseaseAmerican Journal of Clinical Pathology, 2008
- Severe Acute Respiratory Syndrome: Temporal Lung Changes at Thin-Section CT in 30 PatientsRadiology, 2004
- Elevated Soluble ST2 Protein Levels in Sera of Patients with Asthma with an Acute ExacerbationAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Acute eosinophilic pneumonia with increased soluble ST2 in serum and bronchoalveolar lavage fluidRespiratory Medicine, 2001